Saturday, November 15, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Nasdaq Stock: Inflation Data Looms as Tech Rally Hangs in Balance

Andreas Sommer by Andreas Sommer
August 12, 2025
in Stocks
0
Nasdaq Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

The Nasdaq opened the week with mixed signals, slipping 0.3% on Monday despite futures briefly flirting with record highs. Investors brace for a pivotal week as US consumer price data—expected to show core inflation rising to 3.0%, well above the Federal Reserve’s 2% target—could dictate the tech-heavy index’s trajectory. While strong earnings (73% of companies beat profit forecasts) buoy sentiment, trade tensions and stagflation fears lurk beneath the surface. A reported deal requiring chip giants to forfeit 15% of China-related revenue for export licenses adds uncertainty, though markets still price in a 90% chance of September rate cuts.

Fed Policy Crossroads

Tuesday’s inflation print presents a double-edged sword: Higher numbers may delay anticipated monetary easing, while lower figures could fuel recession concerns. The Nasdaq’s recent rally—now just 0.2% off record highs—faces a stress test as conflicting forces collide. With the Fed chair’s term ending soon and trade truces offering temporary relief, tech stocks navigate a precarious balance between growth optimism and macroeconomic headwinds. The next 48 hours may determine whether the sector sustains momentum or stumbles.

Ad

Nasdaq Stock: Buy or Sell?! New Nasdaq Analysis from November 15 delivers the answer:

The latest Nasdaq figures speak for themselves: Urgent action needed for Nasdaq investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 15.

Nasdaq: Buy or sell? Read more here...

Tags: Nasdaq
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Micron Stock

Micron Stock: Soars on AI-Driven Memory Boom

Ballard Power Stock

Ballard Power Stock: Struggles Amid Strategic Shift

Hannover Rueck Stock

Hannover Rueck Stock: Record Profits Defy Market Challenges

Recommended

Kraft Heinz Stock

Kraft Heinz Shares Plummet as Weak Sales and Corporate Split Plans Rattle Investors

1 week ago
PowerFleet Stock

PowerFleet Shares Surge on Artificial Intelligence Momentum

2 days ago
FCBC stock news

Krane Funds Advisors LLC Acquires Stake in Avista Co. and Highlights Lucrative Dividend Opportunity in Utilities Sector

2 years ago
Unitedhealth Stock

Major Investors Split on UnitedHealth’s Prospects as Billionaires Buy While Morgan Stanley Exits

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Diginex’s Bold AI Acquisition Signals Strategic Pivot

Fuel Cell Titans: Ballard Power’s Financial Muscle Versus PowerCell’s Margin Excellence

Red Cat Shares Plunge Following Quarterly Earnings Release

Meta’s AI Ambitions Spark Investor Anxiety Despite Record Earnings

PayPal Shares Face Mounting Pressure as Downgrade Sparks Sell-Off

Solana’s Contradiction: Institutional Accumulation Meets Retail Exodus

Trending

Inhibrx Biosciences Stock
Earnings

Inhibrx Biosciences Shares Surge on Clinical Breakthrough

by Dieter Jaworski
November 15, 2025
0

The stock of clinical-stage biopharmaceutical company Inhibrx Biosciences has experienced a dramatic ascent, appreciating by a remarkable...

Campbell Soup Stock

Campbell Soup Faces Analyst Skepticism Despite Institutional Backing

November 15, 2025
Elys Game Technology Stock

Elys Game Technology Shares Approach Critical Juncture

November 15, 2025
Diginex Stock

Diginex’s Bold AI Acquisition Signals Strategic Pivot

November 15, 2025
Ballard Power Stock

Fuel Cell Titans: Ballard Power’s Financial Muscle Versus PowerCell’s Margin Excellence

November 15, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Inhibrx Biosciences Shares Surge on Clinical Breakthrough
  • Campbell Soup Faces Analyst Skepticism Despite Institutional Backing
  • Elys Game Technology Shares Approach Critical Juncture

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com